Back
Fifth Third Bancorp Vs. 4D Molecular Therapeutics Industry Stock Comparison
Buy
59
FITB
Fifth Third Bancorp
Last Price:
36.93
Seasonality Move:
3.74%
Sell
16
FDMT
4D Molecular Therapeutics
Last Price:
23.21
Seasonality Move:
-20.46%
Buy
59
Fifth Third Bancorp (FITB)
is a Buy
Is Fifth Third Bancorp a Buy, Sell or Hold?
- The current Fifth Third Bancorp [FITB] share price is $36.90. The Score for FITB is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- FITB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
16
4D Molecular Therapeutics (FDMT)
is a Sell
Is 4D Molecular Therapeutics a Buy, Sell or Hold?
- The current 4D Molecular Therapeutics [FDMT] share price is $23.25. The Score for FDMT is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- FDMT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
FITB Stock Price Chart
What is Fifth Third Bancorp's stock price today?
-
The Fifth Third Bancorp share price today is $36.90
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FITB is experiencing slight selling pressure.
FDMT Stock Price Chart
What is 4D Molecular Therapeutics's stock price today?
-
The 4D Molecular Therapeutics share price today is $23.25
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FDMT is experiencing slight selling pressure.
FITB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.31 | Buy |
| Relative Strength Index (14 RSI): | 59.38 | Buy |
| Chaikin Money Flow: | -433219 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.85 - 36.85) | Buy |
| Bollinger Bands (100): | (33.07 - 36.23) | Buy |
FDMT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.44 | Sell |
| Relative Strength Index (14 RSI): | 34.11 | Sell |
| Chaikin Money Flow: | -30640 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.57 - 31.31) | Sell |
| Bollinger Bands (100): | (18.43 - 29.93) | Sell |
FITB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.14 | Buy |
| 20-day SMA: | 35.68 | Buy |
| 50-day SMA: | 35.47 | Buy |
| 200-day SMA: | 30.48 | Buy |
| 8-day EMA: | 36.38 | Buy |
| 20-day EMA: | 35.92 | Buy |
| 50-day EMA: | 35.35 | Buy |
| 200-day EMA: | 32.24 | Buy |
FDMT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.7 | Sell |
| 20-day SMA: | 26.48 | Sell |
| 50-day SMA: | 28.52 | Sell |
| 200-day SMA: | 19.19 | Buy |
| 8-day EMA: | 24.68 | Sell |
| 20-day EMA: | 26.35 | Sell |
| 50-day EMA: | 26.76 | Sell |
| 200-day EMA: | 21.52 | Buy |
Fifth Third Bancorp Earnings Growth & FITB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.24 per share, and an increase next year of $0.29 per share.
4D Molecular Therapeutics Earnings Growth & FDMT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.32 per share.
Fifth Third Bancorp Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
4D Molecular Therapeutics Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||